The weekly litigation news digest is live. Subscribe now

IP Verse

Heterodimers Of Glutamic Acid - EP3335736

The patent EP3335736 was granted to Molecular Insight Pharmaceuticals on Dec 30, 2020. The application was filed on Nov 7, 2007 under application number EP18150494A. The patent is currently recorded with a legal status of "Revoked".

EP3335736

MOLECULAR INSIGHT PHARMACEUTICALS
Application Number
EP18150494A
Filing Date
Nov 7, 2007
Status
Revoked
Jun 24, 2022
Publication Date
Dec 30, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS UNIVERSITAT HEIDELBERGSep 30, 2021KILGERADMISSIBLE
POLSERVICE KANCELARIA RZECZNIKOW PATENTOWYCH SP Z OOSep 30, 2021KAWCZYNSKAADMISSIBLE
LEWIS SILKINSep 23, 2021GAUNTWITHDRAWN

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2004002478
DESCRIPTIONUS2004054190
DESCRIPTIONWO0222627
DESCRIPTIONWO03060523
OPPOSITIONUS2004054190
OPPOSITIONWO0222627
OTHEREP2097111
OTHEREP2942065
OTHERWO2008058192

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents